This activity is supported by educational grants from Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., Mallinckrodt LLC, Pentax of America, Inc., Pfizer, Inc., Salix Pharmaceuticals, a Division of Bausch Health, and Takeda Pharmaceuticals U.S.A. Inc.
The Southern California Society of Gastroenterology (SCSG) thanks you for joining us at the 2019 Liver Symposium, held December 7-8, at the Montage in Laguna Beach, CA.
The symposium provided a unique opportunity to receive a comprehensive update in chronic liver disease from nationally renowned faculty. The educational lectures at this symposium focused on important advances presented at the annual American Association for the Study of Liver Disease (AASLD) Meeting and/or in recent publications. Attendees also had ample opportunity to interact with colleagues, our expert faculty members, and industry representatives.
For questions or inquiries, please contact the SCSG via email at email@example.com.
This activity has been designed to meet the educational needs of physicians, physician assistants, and nurse practitioners involved in the care of patients with chronic liver disease.
Statement of Need
The goal of this program is to provide important clinical and scientific data on the management of chronic liver disease.
Upon completion of this symposium, participants should be better able to:
Describe chronic liver disease (CLD) management recommendations/guidelines for new treatments
Optimize treatment results for patients with CLD, through utilizing new therapies
Identify new advances presented at 2019 AASLD and assess their potential impact on clinical practice
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Southern California Society of Gastroenterology. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
CME and MOC Credit Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Southern California Society of Gastroenterology. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables participants to earn up to 6.75 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosure of Conflicts of Interest
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower and SCSG have no relevant commercial relationships to disclose.
The Liver Symposium Co-Chair Committee
John Donovan, MD
Steven-Huy Han, MD
Paul Pockros, MD